<bill session="114" type="hr" number="95" updated="2018-11-21T21:22:59Z">
  <state datetime="2015-02-05">REFERRED</state>
  <status>
    <introduced datetime="2015-02-05"/>
  </status>
  <introduced datetime="2015-02-05"/>
  <titles>
    <title type="official" as="introduced">Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
    <title type="display">Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.</title>
  </titles>
  <sponsor bioguide_id="V000130"/>
  <cosponsors>
    <cosponsor bioguide_id="H001034" joined="2015-04-23"/>
    <cosponsor bioguide_id="P000608" joined="2015-04-23"/>
  </cosponsors>
  <actions>
    <action datetime="2015-02-05">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-02-05" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-02-06">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Advanced technology and technological innovations"/>
    <term name="Biological and life sciences"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Health programs administration and funding"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Research administration and funding"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2015-02-05T05:00:00Z" status="Introduced in House">Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.</summary>
  <committee-reports/>
</bill>
